09.15.15
Lyon, France-based Medicrea Group, which makes surgical technologies for the treatment of spinal pathologies, has named Gregory Rhinehart has joined the company’s U.S.-based subsidiary, Medicrea USA Corp., as vice president of sales. The U.S. subsidiary is based in New York, N.Y.
Rhinehart will report to Pierre Olivier, CEO of Medicrea USA, while Colby McMillan, who previously served as the vice president of sales for the United States, has been promoted to the position of vice president of product development U.S.
"Greg brings more than 15 years of spine expertise and an excellent track-record of execution to the company,” said Denys Sournac, chairman and CEO of Medicrea. “His leadership will be instrumental in taking our U.S. subsidiary into its next phase of growth. As we lead the transformation into personalized spine treatment through our current portfolio of differentiated product and services, such as 3D printing and our UNiD patient specific rods, it is essential to take our sales organization to the next level. Greg’s leadership will help us continue to deliver superior services to surgeons and their teams and re-accelerate our growth and value creation in the US market."
“I am very excited to join such a passionate team dedicated to personalized medicine in the spine,” said Rhinehart. “Medicrea’s personalized spine focus, along with its differentiated portfolio, uniquely positions the company to benefit from the rapidly changing spine market in the United States, where the value proposition for the patients, surgeons and hospitals are being reinvented. The company has already laid the core foundations required to execute this ambitious vision and I look forward to helping further this mission.”
Rhinenart was formerly the vice president of sales for Central U.S. at Globus Medical. There, he was in charge of $105 million in revenue. During his tenure at Globus, he led a team of 77 salespeople, including area directors and sales representatives. From 2006 to 2015, Rhinehart implemented and executed a hybrid model using both direct sales people and distributors to deliver high growth and hit profitability targets.
Before joining Globus, Rhinehart worked for DePuy Synthes Spine and Medtronic, both in sales and surgeon education positions.
Rhinehart will report to Pierre Olivier, CEO of Medicrea USA, while Colby McMillan, who previously served as the vice president of sales for the United States, has been promoted to the position of vice president of product development U.S.
"Greg brings more than 15 years of spine expertise and an excellent track-record of execution to the company,” said Denys Sournac, chairman and CEO of Medicrea. “His leadership will be instrumental in taking our U.S. subsidiary into its next phase of growth. As we lead the transformation into personalized spine treatment through our current portfolio of differentiated product and services, such as 3D printing and our UNiD patient specific rods, it is essential to take our sales organization to the next level. Greg’s leadership will help us continue to deliver superior services to surgeons and their teams and re-accelerate our growth and value creation in the US market."
“I am very excited to join such a passionate team dedicated to personalized medicine in the spine,” said Rhinehart. “Medicrea’s personalized spine focus, along with its differentiated portfolio, uniquely positions the company to benefit from the rapidly changing spine market in the United States, where the value proposition for the patients, surgeons and hospitals are being reinvented. The company has already laid the core foundations required to execute this ambitious vision and I look forward to helping further this mission.”
Rhinenart was formerly the vice president of sales for Central U.S. at Globus Medical. There, he was in charge of $105 million in revenue. During his tenure at Globus, he led a team of 77 salespeople, including area directors and sales representatives. From 2006 to 2015, Rhinehart implemented and executed a hybrid model using both direct sales people and distributors to deliver high growth and hit profitability targets.
Before joining Globus, Rhinehart worked for DePuy Synthes Spine and Medtronic, both in sales and surgeon education positions.